Patents-Review.com
ClassID:

93342 ⎘

C07C309/15 - CPC Classification

Classification description:

Sulfonic acids; Halides, esters, or anhydrides thereof; Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups , X being a hetero atom, Y being any atom

Recent Application in this class:
#1
20260042949
2026-02-12

WELLBORE FLUIDS INCLUDING EMULSIFIERS, AND RELATED METHODS

 #2
20260035343
2026-02-05

NOVEL SULFOBETAINE MONOMERS, PROCESS FOR PREPARING SAME, AND USES THEREOF

 #3
20260035342
2026-02-05

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF

 #4
20250109100
2025-04-03

CRYSTALLINE FORM OF 3- ((L-VALYL) AMINO) -I-PROPANESULFONIC ACID

 #5
20250009693
2025-01-09

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

 #6
20250002629
2025-01-02

AMINO ACID-BASED POLYMERIZABLE COMPOUNDS AND OPHTHALMIC DEVICES PREPARED THEREFROM

 #7
20240158343
2024-05-16

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF

 #8
20240065990
2024-02-29

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

 #9
20230404954
2023-12-21

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

 #10
20230295079
2023-09-21

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF

 #11
20230183603
2023-06-15

Cleavable surfactants

 #12
20230183174
2023-06-15

NOVEL SULFOBETAINE MONOMERS, PROCESS FOR PREPARING SAME, AND USES THEREOF

 #13
20230139837
2023-05-04

Photo-cleavable surfactants

 #14
20230121825
2023-04-20

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

 #15
20220332680
2022-10-20

Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid

 #16
20220289672
2022-09-15

Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid

 #17
20220227704
2022-07-21

Process for filtering 2-acrylamido-2-methylpropane sulfonic acid

 #18
20220144766
2022-05-12

Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof

 #19
20220002239
2022-01-06

A CRYSTALLINE FORM OF 3- ((L-VALYL) AMINO) -1-PROPANESULFONIC ACID

 #20
20210388142
2021-12-16

Amino acid-based polymerizable compounds and ophthalmic devices prepared therefrom

 #21
20210386693
2021-12-16

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

 #22
20210347731
2021-11-11

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF

 #23
20210284599
2021-09-16

Amide compounds, pharmaceutical compositions thereof, and methods of using the same

 #24
20210253519
2021-08-19

Photo-cleavable surfactants

 #25
20210179550
2021-06-17

Phenyl urea derivatives as N-formyl peptide receptor modulators

 #26
20210163405
2021-06-03

Enhanced conversion of taurine to alkyl taurate amide using phosphoric acid catalysts

 #27
20210053914
2021-02-25

Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof

 #28
20210040058
2021-02-11

Acid-labile surfactants

 #29
20200392078
2020-12-17

Production process for magnesium N-acetyl taurinate

 #30
20200377449
2020-12-03

Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid

 #31
20200375930
2020-12-03

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

 #32
20200283379
2020-09-10

Method of enhanced conversion of taurine salts to alkyl taurate amides

 #33
20200263110
2020-08-20

Cleavable surfactants

 #34
20200253897
2020-08-13

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

 #35
20200223793
2020-07-16

Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof

 #36
20200087186
2020-03-19

Method for treating a suspension of solid particles in water using a (co)polymer of a hydrated crystalline form of 2-acrylamido-2-methylpropanesulfonic acid

 #37
20200079992
2020-03-12

Enhanced oil recovery method using a (co)polymer of a hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid

 #38
20200048535
2020-02-13

Fracturing fluid comprising a (co)polymer of a hydrated crystalline form of 2-acrylamido-2-methylpropane sulphonic acid and hydraulic fracturing method

 #39
20200031765
2020-01-30

Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid

 #40
20200024228
2020-01-23

Method for producing 2-acrylamido-2-methylpropane sulphonic acid

 #41
20200009086
2020-01-09

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

 #42
20190330144
2019-10-31

Glucagon antagonists

 #43
20190315680
2019-10-17

Inhibitors of creatine transport and uses thereof

 #44
20190241509
2019-08-08

Compound comprising certain level of bio-based carbon

 #45
20190218176
2019-07-18

Antagonists of the glucagon receptor

 #46
20190060858
2019-02-28

Composition comprising a fluorine-containing surfactant

 #47
20180364571
2018-12-20

Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device

 #48
20180275512
2018-09-27

Resist composition and patterning process

 #49
20180273471
2018-09-27

Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof

 #50
20180267402
2018-09-20

Resist composition and patterning process

 #51
20180187127
2018-07-05

Cleavable surfactants

 #52
20180022695
2018-01-25

Glucagon antagonists

 #53
20170360730
2017-12-21

Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

 #54
20170275246
2017-09-28

Antagonists of the glucagon receptor

 #55
20170218003
2017-08-03

Pharmaceutical compounds

 #56
20170158617
2017-06-08

Fatty amides and derivatives from natural oil metathesis

 #57
20170152331
2017-06-01

Curable composition

 #58
20170095430
2017-04-06

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

 #59
20170050924
2017-02-23

Inhibitors of creatine transport and uses thereof

 #60
20160272581
2016-09-22

Phenylcarbamate derivatives as formyl peptide receptor modulators

 #61
20160137596
2016-05-19

Method for purifying acrylamide alkyl sulfonic acid

 #62
20160116840
2016-04-28

Compound, active light sensitive or radiation sensitive resin composition, resist film using same, resist-coated mask blank, photomask, pattern forming method, method for manufacturing electronic device, and electronic device

 #63
20160009639
2016-01-14

Antagonists of the glucagon receptor

 #64
20150376118
2015-12-31

Imidazoline amides and derivitives from natural oil metathesis

 #65
20150336916
2015-11-26

Epoxyeicosatrienoic acid analogs and methods of making and using the same

 #66
20150203517
2015-07-23

Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs

 #67
20150099781
2015-04-09

Compounds and methods for treating mammalian gastrointestinal microbial infections

 #68
20150087680
2015-03-26

Glucagon antagonists

 #69
20140339462
2014-11-20

Stilbene optical brighteners

 #70
20140228419
2014-08-14

Isocyanate and isothiocyanate compounds for cancer treatment

 #71
20140220122
2014-08-07

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

 #72
20140135400
2014-05-15

Antagonists of the glucagon receptor

 #73
20140113884
2014-04-24

Epoxyeicosatrienoic acid analogs and methods of making and using the same

 #74
20140073610
2014-03-13

Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers

 #75
20130274230
2013-10-17

(2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators

 #76
20130190417
2013-07-25

Polymerizable gemini dicarboxlate surfactants and lyotropic liquid crystals and membranes made therefrom

 #77
20130137893
2013-05-30

Process for preparing and purifying salts of acrylamido-2-methylpropanesulfonic acid

 #78
20130058990
2013-03-07

Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent

 #79
20130030201
2013-01-31

Method for preparing fatty acyl amido carboxylic acid based surfactants

 #80
20130030199
2013-01-31

Amino acid salt containing compositions

 #81
20130030198
2013-01-31

General method for preparing fatty acyl amido based surfactants

 #82
20130030197
2013-01-31

Fatty acyl amido based surfactant concentrates

 #83
20130030029
2013-01-31

Glucagon antagonists

 #84
20120225937
2012-09-06

CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PG12 RECEPTOR AGONISTS

 #85
20120214769
2012-08-23

Antagonists of the glucagon receptor

 #86
20120101096
2012-04-26

Compounds and methods for treating mammalian gastrointestinal microbial infections

 #87
20120090983
2012-04-19

Continuous Method For Acylating Amino Group-Carrying Organic Acids

 #88
20120028927
2012-02-02

Triazene compounds for the treatment of cancer

 #89
20120015909
2012-01-19

MAO-B INHIBITORS USEFUL FOR TREATING OBESITY

 #90
20110319267
2011-12-29

Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers

 #91
20110251248
2011-10-13

Glucagon receptor antagonist compounds

 #92
20110196041
2011-08-11

Crystal form of calcium 3-acetylaminopropane-1-sulfonate

 #93
20110182953
2011-07-28

POLYMORPHIC FORM OF CALCIUM ACAMPROSATE

 #94
20110118356
2011-05-19

Insecticidal compounds

 #95
20110118303
2011-05-19

Compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these

 #96
20110087048
2011-04-14

Polymerizable sulfonate ionic liquids and liquid polymers therefrom and methods of making same

 #97
20110053958
2011-03-03

Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

 #98
20100317884
2010-12-16

Polymerizable sulfonate ionic liquids and liquid polymers therefrom

 #99
20100317582
2010-12-16

Cyclic hydrocarbon compounds for the treatment of diseases

 #100
20100274048
2010-10-28

2-acrylamide-2-methylpropanesulfonic acid and process for producing the same

 #101
20100234452
2010-09-16

Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders

 #102
20100234327
2010-09-16

Triazene compounds for the treatment of cancer

 #103
20100233610
2010-09-16

Polymer having a sulfonic group or a sulfonate group and an amide group and method of producing same

 #104
20100228035
2010-09-09

Functionalized ionic liquids, and methods of use thereof

 #105
20100190753
2010-07-29

Methods and Compositions for Treating Amyloid-Related Diseases

 #106
20100152465
2010-06-17

Functionalized Ionic Liquids, and Methods of Use Thereof

 #107
20100121023
2010-05-13

POLYMER HAVING A SULFONIC GROUP OR A SULFONATE GROUP AND AN AMIDE GROUP AND METHOD OF PRODUCING SAME

 #108
20100120744
2010-05-13

ACETAMIDOPROPANE MODULATORS OF NMDA RECEPTORS

 #109
20100113591
2010-05-06

Methods and compositions for treating amyloid-related diseases

 #110
20100087496
2010-04-08

NOVEL CINNAMIC AMIDE DERIVATIVES USEFUL AS ION CHANNEL MODULATORS

 #111
20090291864
2009-11-26

Viscoelastic compositions

 #112
20090264525
2009-10-22

Fluorosurfactants

 #113
20090187011
2009-07-23

Method of serum pre-treatment for glycomic analysis

 #114
20090095628
2009-04-16

Cleavable surfactants

 #115
20090082464
2009-03-26

EXTERNALLY MASKED NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE

 #116
20090082440
2009-03-26

Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use

 #117
20090076147
2009-03-19

Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use

 #118
20090069419
2009-03-12

MASKED CARBOXYLATE NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE

 #119
20080146642
2008-06-19

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

 #120
20080112866
2008-05-15

Functionalized ionic liquids, and methods of use thereof

 #121
20080051605
2008-02-28

Polymerizable sulfonate ionic liquids and liquid polymers therefrom

 #122
20080015180
2008-01-17

Methods and compositions for treating amyloid-related diseases

 #123
20070111125
2007-05-17

Charge controlling agent and toner

 #124
20070059627
2007-03-15

Polymer having a sulfonic group or a sulfonate group and an amide group and method of producing same

 #125
20070010573
2007-01-11

Methods and compositions for treating amyloid-related diseases

 #126
20070004774
2007-01-04

Cept inhibitors and metabolites thereof

 #127
20070004683
2007-01-04

MAO-B inhibitors useful for treating obesity

 #128
20060183800
2006-08-17

Methods and fluorinated compositions for treating amyloid-related diseases

 #129
20050272631
2005-12-08

Organic activator

 #130
20050124525
2005-06-09

Anionic viscoelastic surfactant

 #131
20050096385
2005-05-05

Methods and compositions for treating amyloid-related diseases

 #132
20050038117
2005-02-17

Methods and compositions for treating amyloid-related diseases

 #133
20050038000
2005-02-17

Methods and compositions for the treatment of amyloid-and epileptogenesis-associated diseases